SYNH Syneos Health Inc

Price (delayed)

$94.34

Market cap

$9.76B

P/E Ratio

41.74

Dividend/share

N/A

EPS

$2.26

Enterprise value

$12.67B

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to ...

Highlights
The net income is up by 26% year-on-year and by 19% since the previous quarter
Syneos Health's EPS has increased by 25% YoY and by 19% QoQ
The P/E is 15% above the last 4 quarters average of 36.3
Syneos Health's debt has increased by 4.4% YoY

Key stats

What are the main financial stats of SYNH
Market
Shares outstanding
103.48M
Market cap
$9.76B
Enterprise value
$12.67B
Valuations
Price to earnings (P/E)
41.74
Price to book (P/B)
3.04
Price to sales (P/S)
2.07
EV/EBIT
37.08
EV/EBITDA
22.32
EV/Sales
2.68
Earnings
Revenue
$4.73B
EBIT
$341.69M
EBITDA
$567.57M
Free cash flow
$443.85M
Per share
EPS
$2.26
Free cash flow per share
$4.27
Book value per share
$31.05
Revenue per share
$45.51
TBVPS
$23.08
Balance sheet
Total assets
$8.02B
Total liabilities
$4.78B
Debt
$3.17B
Equity
$3.24B
Working capital
$151.95M
Liquidity
Debt to equity
0.98
Current ratio
1.1
Quick ratio
1.02
Net debt/EBITDA
5.12
Margins
EBITDA margin
12%
Gross margin
23.8%
Net margin
5%
Operating margin
7.5%
Efficiency
Return on assets
3%
Return on equity
7.4%
Return on invested capital
9.6%
Return on capital employed
5.3%
Return on sales
7.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SYNH stock price

How has the Syneos Health stock price performed over time
Intraday
0.64%
1 week
0.04%
1 month
5.38%
1 year
72.34%
YTD
38.47%
QTD
5.42%

Financial performance

How have Syneos Health's revenue and profit performed over time
Revenue
$4.73B
Gross profit
$1.12B
Operating income
$353.9M
Net income
$235.93M
Gross margin
23.8%
Net margin
5%
The company's operating income rose by 49% YoY and by 16% QoQ
SYNH's operating margin is up by 44% year-on-year and by 10% since the previous quarter
The net income is up by 26% year-on-year and by 19% since the previous quarter
Syneos Health's net margin has increased by 22% YoY and by 14% QoQ

Growth

What is Syneos Health's growth rate over time

Valuation

What is Syneos Health stock price valuation
P/E
41.74
P/B
3.04
P/S
2.07
EV/EBIT
37.08
EV/EBITDA
22.32
EV/Sales
2.68
Syneos Health's EPS has increased by 25% YoY and by 19% QoQ
The P/E is 15% above the last 4 quarters average of 36.3
SYNH's price to book (P/B) is 32% higher than its last 4 quarters average of 2.3 but 5% lower than its 5-year quarterly average of 3.2
Syneos Health's equity has increased by 8% YoY
The price to sales (P/S) is 48% higher than the 5-year quarterly average of 1.4 and 29% higher than the last 4 quarters average of 1.6
SYNH's revenue is up by 6% from the previous quarter and by 3.6% YoY

Efficiency

How efficient is Syneos Health business performance
SYNH's ROIC is up by 35% YoY and by 13% from the previous quarter
Syneos Health's return on sales has increased by 31% YoY and by 7% QoQ
Syneos Health's return on assets has increased by 20% YoY and by 15% QoQ
Syneos Health's return on equity has increased by 17% QoQ and by 17% YoY

Dividends

What is SYNH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SYNH.

Financial health

How did Syneos Health financials performed over time
The total assets is 68% higher than the total liabilities
The total assets rose by 8% YoY
SYNH's total liabilities is up by 8% year-on-year
Syneos Health's debt is 2.2% lower than its equity
Syneos Health's equity has increased by 8% YoY
Syneos Health's debt has increased by 4.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.